Maroney Dawn Christine 4
4 · Alignment Healthcare, Inc. · Filed Jul 16, 2026
Research Summary
AI-generated summary of this filing
Alignment Healthcare President Dawn Maroney Sells Shares, Exercises Options
What Happened Dawn Christine Maroney, President of Alignment Healthcare (ALHC), exercised 152,068 stock options at a $9.06 strike price (cost ≈ $1,377,736) on July 15, 2026. The exercised shares were disposed (cashless/same-day sale), and she also sold 177,068 shares in an open-market transaction for total proceeds of about $3,687,990 (weighted-average price $20.83). The Form 4 was filed on July 16, 2026, covering the July 15 transactions.
Key Details
- Transaction date: 2026-07-15; Form 4 filed: 2026-07-16 (appears timely).
- Option exercise: 152,068 shares exercised at $9.06 per share; aggregate exercise amount ≈ $1,377,736.
- Dispositions: 152,068 shares from the exercise were disposed (derivative-related); plus 177,068 shares sold in the open market.
- Open-market sale price: weighted-average $20.83 per share; reported range $20.29–$21.14 (footnote F2 — reporting person can supply exact breakdown on request).
- Footnote F1: 10b5-1 trading plan adopted 03/13/2026 (prearranged trading plan).
- Footnote F3: Options originally granted 03/08/2022, vesting 25% on each of the first four anniversaries of the grant.
- Shares owned after the transactions: not disclosed in the provided filing.
Context
- The M transaction code indicates exercise/conversion of a derivative (stock options); because the exercised shares were immediately disposed, this reads as a cashless exercise followed by sale rather than a buy-and-hold purchase.
- The presence of a 10b5-1 plan (adopted 03/13/2026) suggests at least some sales were prearranged according to a trading plan, which is common for scheduled insider sales and can limit inference about near-term sentiment.
- No indication in the provided data that the filing was late or that the reporting person is a >10% owner.
Insider Transaction Report
Form 4
Maroney Dawn Christine
President
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-07-15$9.06/sh+152,068$1,377,736→ 1,099,381 total - Sale
Common Stock
[F1][F2]2026-07-15$20.83/sh−177,068$3,687,990→ 922,313 total - Exercise/Conversion
Options (Right to Buy)
[F3]2026-07-15$9.06/sh−152,068$1,377,736→ 0 totalExercise: $9.06Exp: 2032-03-08→ Common Stock (152,068 underlying)
Footnotes (3)
- [F1]Date of adoption of Rule 10b5-1 plan: 3/13/26
- [F2]The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $20.29 to $21.14. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
- [F3]Options vested 25% on each of the first four anniversaries of the grant date (03/08/2022), subject to the reporting person's continued service to the Company as of the applicable vesting date.
Signature
/s/ Christopher J. Joyce, as Attorney-in-Fact, for Dawn C. Maroney|2026-07-16